OakChart

Nano X Imaging Ltd

NNOXHealthcare·Medical Devices·Israel·Nano·NASD·Nov 11 • 1:34 PM ET

0.3750+0.0017 (0.46%)
2026-11-11 19:34 CET
Market cap
29.40 USD m
Revenue, TTM
15.63 USD m
Net income, TTM
-116.81 USD m
Free cash flow, TTM
-55.46 USD m
EPS diluted, TTM
-1.71
P/E
-
Compare

Price

NNOX against its 20, 50 and 200-day averages
2050200miss
1.002.003.0044.6M89.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NNOXclose 0.3820-day 0.3450-day 0.55200-day 1.480.3852w low

92.0% under the 52-week high of 4.71 on 26 Nov 2025. 52-week low 0.21 on 6 Nov 2026. Last 15 sessions, 129.5% high to low

Profile

NNOX
52-week range, 4% of the way up
0.214.70

Nano-X Imaging Ltd. engages in the development of medical imaging systems. It operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.

Employees197
IPOAug 21, 2020
Beta1.33
ATR, 14d0.06
Rel volume4.59
Short float7.93%
Insider own7.37%
Inst own11.84%

Snapshot

6 groups

Valuation

Index-
Market Cap29.53M
Enterprise Value6.24M
Income-116.81M
Sales15.63M
Book/sh1.03
Cash/sh0.39
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees197
IPOAug 21, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S1.89
P/B0.36
P/C0.95
P/FCF-
EV/EBITDA-
EV/Sales0.40
Quick Ratio2.59
Current Ratio2.84
Debt/Eq0.11
LT Debt/Eq0.05
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.71
EPS next Y-0.45
EPS next Q-0.15
EPS this Y-8.91%
EPS next Y64.12%
EPS next 5Y38.74%
EPS past 3/5Y18.87% 1.18%
Sales past 3/5Y14.93% -
EPS Y/Y TTM-89.07%
Sales Y/Y TTM31.52%
EPS Q/Q-244.36%
Sales Q/Q36.71%
EarningsSep 09 BMO
EPS/Sales Surpr.-387.65% -22.69%

Ownership

Insider Own7.37%
Insider Trans4.18%
Inst Own11.84%
Inst Trans-14.76%
ROA-84.82%
ROE-98.98%
ROIC-153.10%
Gross Margin-79.87%
Oper. Margin-387.33%
Profit Margin-747.20%
SMA208.87%
SMA50-31.22%
SMA200-74.75%
Trades-

Technical

Shs Outstand78.75M
Shs Float72.94M
Short Float7.93%
Short Ratio2.31
Short Interest5.78M
52W High4.70 -92.03%
52W Low0.21 80.90%
Volatility31.95% 15.18%
ATR (14)0.06
RSI (14)46.05
Beta1.33
Rel Volume4.59
Avg Volume2.51M
Volume7,417,155

Performance

Perf Week32.98%
Perf Month-27.13%
Perf Quarter-61.93%
Perf Half Y-79.05%
Perf YTD-86.61%
Perf Year-87.90%
Perf 3Y-93.34%
Perf 5Y-98.41%
Perf 10Y-
Recom1.67
Target Price4.13
Prev Close0.37
Price0.38
Change %0.46%

Analyst ratings

latest 8 of 8
DateActionAnalystRating changeTargetImplied
Jul 07, 2026DowngradeAAlliance Global PartnersBuy → Neutral$3+700.0%
Jan 06, 2025InitiatedDD. Boral CapitalBuy$23+6,033.3%
Sep 08, 2023InitiatedAAlliance Global PartnersBuy$14.50+3,766.7%
Jan 05, 2023InitiatedCCantor FitzgeraldOverweight$21+5,500.0%
Apr 19, 2021InitiatedLLadenburg ThalmannBuy$52+13,766.7%
Sep 15, 2020InitiatedOOppenheimerPerform
Sep 15, 2020InitiatedCCantor FitzgeraldOverweight$70+18,566.7%
Sep 15, 2020InitiatedBBerenbergBuy$65+17,233.3%

Peers

Mkt cap
TickerCompanyMkt cap
HYPRHyperfine Inc73.53M
BFLYButterfly Network Inc1.85B
QTIQT Imaging Holdings Inc31.54M
VREXVarex Imaging Corp783.61M
LMRILumexa Imaging Holdings Inc1.53B
PLSMPulsenmore Ltd12.91M
NDRAENDRA Life Sciences Inc7.02M
RDNTRadnet Inc6.18B
ONMDOneMedNet Corp32.89M
HTFLHeartflow Inc5.20B

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Meltzer ErezChief Executive OfficerOct 19 '26Buy0.4525,00011,25090,443Oct 20 06:01 AM
Meltzer ErezChief Executive OfficerSep 15 '26Buy0.6910,0006,90065,443Sep 16 06:14 AM
Suesskind Dan SDirectorSep 14 '26Buy0.7660,00045,300110,000Sep 15 08:00 AM
Meltzer ErezChief Executive OfficerSep 10 '26Buy0.7810,0007,80055,443Sep 14 07:59 AM
Meltzer ErezChief Executive OfficerAug 10 '26Buy1.039,4439,72645,443Aug 11 09:24 AM
Daniel RanOfficerAug 03 '26Proposed Sale0.985,9505,831Aug 04 08:51 AM
Suesskind Dan SDirectorJul 27 '26Buy0.9350,00046,50050,000Jul 29 07:40 AM
Kainan NogaDirectorJul 28 '26Buy0.9033,00029,70040,792Jul 29 07:35 AM
Daniel RanOfficerJul 30 '26Proposed Sale0.881,000880Jul 28 09:37 PM
Meltzer ErezChief Executive OfficerJul 27 '26Buy0.9336,00033,48036,000Jul 28 04:54 PM
Alroy ErezDirectorJun 10 '26Sale1.656781,1196,753Jun 15 04:05 PM

Held by

AUM
TickerCompanyAUM
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-09-09-0.790-0.162-0.7904.165.383
2026Q12026-06-25-0.200-0.200-0.2054.314.543
2025Q42026-04-20-0.500-0.230-0.4983.724.252
2025Q32025-11-20-0.210-0.213-0.2133.453.503
2025Q22025-08-12-0.230-0.191-0.2303.043.204
2025Q12025-05-22-0.210-0.193-0.2072.823.984
2024Q42025-03-31-0.230-0.227-0.2343.003.803
2024Q32024-11-21-0.230-0.217-0.2333.033.912
2024Q22024-08-20-0.230-0.216-0.2342.703.933
2024Q12024-05-28-0.210-0.260-0.2112.554.422
2023Q42024-04-01-0.180-0.303-0.1772.402.823
2023Q32023-11-28-0.370-0.300-0.3752.482.901
2023Q22023-08-17-0.310-0.265-0.3142.583.162
2023Q12023-05-22-0.210-0.340-0.2132.452.902
2022Q42023-03-09-0.860-0.430-0.8552.132.653
2022Q32022-11-10-0.370-0.420-0.3662.442.823

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-0.530-0.787-1.2290.000.00
2021FY-1.260-1.337-1.2821.300.75
2022FY-2.010-1.557-2.1688.589.07
2023FY-1.080-1.213-1.0789.9110.32
2024FY-0.910-0.890-0.91211.2811.89
2025FY-1.160-0.880-1.16013.0213.55
2026FY--1.263--19.76
2027FY--0.453--31.97
2028FY--0.267--47.94
2029FY--0.300--56.11
2030FY--0.140--89.26

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-09-163035.344.586.33
2026Q3S2026-09-123025.494.586.80
2026Q3S2026-09-113035.494.586.80
2026Q3S2026-09-093026.924.589.39
2026Q3S2026-09-083027.285.659.39
2026Q3S2026-08-143127.285.659.39
2026Q3S2026-07-023127.285.659.40
2026Q3S2026-06-293117.746.809.40
2026Q3S2026-06-253108.307.039.40
2026Q3S2026-06-243008.247.039.20
2026Q3S2026-06-123108.247.039.20
2026Q3S2026-05-213218.247.039.20
2026Q3S2026-04-214218.387.039.20
2026Q3S2026-04-203208.828.489.20

Estimate history

EPS, annual-0.042-0.494-1.229-1.282-2.168-1.078-0.912-1.158-1.7088
Period20182019202020212022202320242025TTM
EPS, quarterly-0.234-0.233-0.234-0.207-0.23-0.213-0.498-0.205-0.793
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0001.3048.5789.90511.28313.02115.63
Period20182019202020212022202320242025TTM
Sales, quarterly2.6993.03132.8153.043.4473.7194.3114.156
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual45.71745.71746.151.79155.09457.77963.76269.5970.061
Period20182019202020212022202320242025MRQ
Shares, quarterly58.49758.52263.76263.81963.76263.76269.5969.60170.061
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue15.6313.0211.289.908.581.300.000.000.00
Cost of Goods Sold Incl. D&A28.1225.9622.0116.5415.813.040.210.050.04
Gross Profit-12.49-12.94-10.72-6.64-7.23-1.74-0.21-0.05-0.04
Selling, General and Administrative Excl. Other48.0746.3445.8551.9464.0558.6443.7222.521.87
Research and Development18.9319.2420.1826.0526.5117.129.212.720.67
Other Operating Expense0.000.000.000.00--0.000.000.00
Operating Income-60.55-59.28-56.58-58.58-71.29-60.38-43.92-22.57-1.90
Interest Expense-----0.29--0.01
Unusual Expense58.2717.540.085.4438.230.000.000.000.00
Net Income Before Taxes-118.57-76.81-53.87-61.12-116.92-61.85-43.82-22.56-1.91
Income Taxes-1.76-1.79-0.36-0.34-3.68-0.050.000.000.00
Consolidated Net Income-116.81-75.02-53.52-60.78-113.24-61.80-43.82-22.56-1.91
Net Income From Continuing Operations-116.81-75.02-53.52-60.78-113.24-61.80-43.82-22.56-1.91
Net Income-116.81-75.02-53.52-60.78-113.24-61.80-43.82-22.56-1.91
EPS (Recurring)-1.09-0.97-0.91-1.01-1.66-1.28-1.23-0.49-0.04
EPS (Basic, Before Extraordinaries)-1.71-1.16-0.91-1.08-2.17-1.28-1.23-0.49-0.04
EPS (Diluted)-1.71-1.16-0.91-1.08-2.17-1.28-1.23-0.49-0.04
EBITDA-49.11-47.58-44.84-46.77-59.77-58.08-43.72-22.52-1.87
Non-Operating Income (Expense)0.300.002.782.90-7.40-1.180.110.010.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.863.315.595.4014.3414.4824.7816.250.12
Price To Sales Ratio5.1913.9337.4436.2544.94537.62---
Gross Margin-79.87-99.39-95.05-67.02-84.32-133.44---
Operating Margin-387.33-455.23-501.42-591.39-831.04-4,630.06---
Net Margin-747.20-576.13-474.31-613.59-1,320.16-4,739.11---
Shares Outstanding70.0669.5963.7657.7855.0951.7946.1045.7245.72
Market Capitalization29.4029.40421.20364.96385.34695.902,080.632,212.32-

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue4.164.313.723.453.042.813.003.03
Cost of Goods Sold Incl. D&A7.257.017.446.436.385.965.995.94
Gross Profit-3.09-2.70-3.72-2.98-3.34-3.15-2.99-2.91
Selling, General and Administrative Excl. Other11.9412.0912.7811.2511.0710.9611.9711.25
Research and Development4.714.804.844.594.834.985.404.75
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-15.03-14.79-16.50-14.23-14.41-14.10-14.96-14.16
Interest Expense0.05---0.15---
Unusual Expense40.710.0317.540.000.030.000.010.00
Net Income Before Taxes-55.54-14.19-35.07-13.78-14.64-13.33-14.16-13.73
Income Taxes-0.050.08-1.69-0.090.08-0.09-0.09-0.09
Consolidated Net Income-55.49-14.27-33.37-13.68-14.72-13.24-14.06-13.64
Net Income From Continuing Operations-55.49-14.27-33.37-13.68-14.72-13.24-14.06-13.64
Net Income-55.49-14.27-33.37-13.68-14.72-13.24-14.06-13.64
EPS (Recurring)-0.39-0.20-0.31-0.21-0.23-0.21-0.23-0.23
EPS (Basic, Before Extraordinaries)-0.79-0.20-0.50-0.21-0.23-0.21-0.23-0.23
EPS (Diluted)-0.79-0.20-0.50-0.21-0.23-0.21-0.23-0.23
EBITDA-12.21-11.97-13.65-11.27-11.46-11.16-12.03-11.23
Non-Operating Income (Expense)0.250.63-1.030.45-0.050.780.810.43
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.690.660.640.870.860.901.091.79
Price To Sales Ratio5.1910.8914.4219.3527.8027.6738.3833.37
Gross Margin-74.35-62.58-100.00-86.42-109.77-111.76-99.57-95.97
Operating Margin-361.65-343.08-443.67-412.88-473.91-501.03-498.70-467.14
Net Margin-1,335.11-330.90-897.36-396.98-484.28-470.30-468.70-449.98
Shares Outstanding70.0669.6069.5963.7663.7663.8263.7658.52
Market Capitalization29.40144.74178.53235.92329.65292.21421.20355.68

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments59.6173.2182.4377.6288.71213.478.070.01
Short Term Receivables2.011.801.480.981.050.000.000.00
Inventories3.071.492.360.000.000.000.000.00
Other Current Assets2.102.182.373.865.096.331.561.69
Total Current Assets66.7978.6888.6482.4694.86219.799.641.70
Net Property, Plant & Equipment33.2049.2046.9244.7039.1615.380.750.16
Total Investments and Advances0.360.340.3325.2667.970.320.140.00
Intangible Assets60.1870.0080.6198.64160.12--0.00
Other Assets1.6311.792.162.871.060.661.340.00
Total Assets162.16210.00218.65253.93363.17236.1511.871.85
Short Term Debt Incl. Current Port. of LT Debt4.093.814.350.740.880.520.140.00
Accounts Payable2.892.213.303.623.130.430.000.00
Other Current Liabilities9.927.967.8720.7148.743.5320.128.24
Total Current Liabilities16.8913.9715.5225.0752.754.4820.268.24
Long Term Debt3.773.644.043.884.750.920.390.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.602.582.953.337.06---
Other Liabilities1.180.690.614.976.460.000.000.00
Total Liabilities22.4320.8823.1337.2571.025.4020.658.24
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity139.73189.12195.51216.68292.15230.75-8.78-6.38
Total Shareholders Equity139.73189.12195.51216.68292.15230.75-8.78-6.38
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity139.73189.12195.51216.68292.15230.75-8.78-6.38
Total Liabilities & Stockholders Equity162.16210.00218.65253.93363.17236.1511.871.85
Book Value Per Share2.012.973.383.935.645.01-0.19-0.14
Tangible Book Value Per Share1.141.871.992.142.555.01-0.19-0.14
Full-Time Employees1971651641801865020-
Price to Book Ratio0.362.571.821.562.589.129.25-
Return on Assets-40.31-24.97-25.72-36.70-20.62-35.33-328.76-
Return on Equity-45.62-27.83-29.49-44.51-23.64-39.48--
Return on Invested Capital-52.28-27.76-30.46-51.34-20.81-18.91--
Quick Ratio3.775.525.563.291.8049.060.480.21
Current Ratio3.965.635.713.291.8049.060.480.21

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-123.03-75.02-53.52-60.78-113.24-61.80-43.82-22.56-1.91
Depreciation12.2711.7011.7311.8111.512.290.210.050.04
Other Funds (Non Cash)63.9621.736.6912.0550.6518.8024.7816.250.12
Funds from Operations-48.90-43.56-35.47-37.29-54.82-40.82-18.83-6.27-1.76
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.852.77-1.13-7.4811.432.75-2.660.74-1.91
Cash from Operating Activities-49.75-40.79-36.60-44.78-43.39-38.07-21.49-5.52-3.67
Capital Expenditures-5.71-4.21-2.77-3.30-7.17-23.16-13.94-0.13-0.07
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments14.7233.78-1.7838.7421.78-90.300.000.000.00
Purchase of Investments-0.02-0.02-43.02-0.37-9.46-90.300.000.000.00
Sale Or Maturity of Investments14.7433.8041.2339.1131.240.000.000.000.00
Other Uses-0.21-0.200.000.000.00-2.860.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities8.8029.37-4.5535.4314.61-116.32-13.94-0.13-0.07
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock22.5421.3739.5028.040.953.58240.9913.863.68
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock22.5421.3739.5028.040.953.58240.9913.863.68
Proceedsfrom Stock Options0.000.0037.8327.140.000.000.00-0.340.00
Issuance or Reduction of Debt, Net0.000.000.000.00-0.143.800.000.000.00
Change in Long Term Debt0.000.000.000.00-0.153.800.000.000.00
Issuance of Long Term Debt0.000.000.000.000.003.800.000.000.00
Reduction of Long Term Debt0.000.000.000.00-0.150.000.000.000.00
Net Financing Active Other Cash Flow-0.130.000.00-0.790.000.000.000.000.00
Other Financing Activities Uses-0.130.000.00-0.790.000.000.000.000.00
Cash from Financing Activities22.4121.3739.5027.250.807.38240.9913.863.68
Exchange Rate Effect-0.26-0.100.07-0.06-0.27----
Net Change in Cash-18.799.85-1.5717.85-28.24-147.01205.578.21-0.06
Free Cash Flow-55.46-45.00-39.37-48.08-50.56-61.23-35.42-5.65-3.74
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit--1.98-0.38-0.38-3.73-0.120.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments31.0243.8559.6145.1951.9562.46
Short Term Receivables1.892.212.011.941.881.72
Inventories3.423.273.072.672.251.75
Other Current Assets2.661.992.101.521.402.04
Total Current Assets38.9951.3366.7951.3157.4867.97
Net Property, Plant & Equipment34.9233.9933.2050.3949.8349.17
Total Investments and Advances0.390.370.360.370.360.33
Intangible Assets14.4857.6860.1862.0464.6967.34
Other Assets2.402.411.6311.9811.8711.93
Total Assets91.19145.77162.16176.09184.23196.74
Short Term Debt Incl. Current Port. of LT Debt3.903.934.094.144.223.88
Accounts Payable2.142.392.891.412.291.94
Other Current Liabilities7.687.799.926.837.207.01
Total Current Liabilities13.7114.1216.8912.3913.7112.83
Long Term Debt3.833.713.773.733.733.52
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.410.510.602.292.392.48
Other Liabilities0.761.131.180.960.840.74
Total Liabilities18.7219.4622.4319.3820.6719.57
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity72.47126.31139.73156.71163.56177.16
Total Shareholders Equity72.47126.31139.73156.71163.56177.16
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity72.47126.31139.73156.71163.56177.16
Total Liabilities & Stockholders Equity91.19145.77162.16176.09184.23196.74
Book Value Per Share1.031.812.012.462.572.78
Tangible Book Value Per Share0.830.991.141.481.551.72
Full-Time Employees--197---
Price to Book Ratio0.360.921.141.441.861.68
Return on Assets-84.82-44.40-40.31-30.95-29.30-27.08
Return on Equity-98.98-50.12-45.62-34.75-32.87-30.11
Return on Invested Capital-72.73-10.97-23.26-8.53-8.80-7.33
Quick Ratio2.593.403.773.934.035.16
Current Ratio2.843.643.964.144.195.30

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-57.28-14.27-36.02-15.47-14.84-13.24
Depreciation2.962.823.153.342.972.94
Other Funds (Non Cash)42.700.7219.511.031.321.19
Funds from Operations-11.72-10.82-15.16-11.20-10.64-9.20
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.53-3.143.66-0.841.25-1.13
Cash from Operating Activities-12.25-13.95-11.50-12.04-9.39-10.33
Capital Expenditures-1.05-1.78-0.99-1.88-1.06-0.53
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.3610.460.493.4120.1311.79
Purchase of Investments0.000.00-0.020.000.000.00
Sale Or Maturity of Investments0.3610.460.513.4120.1311.79
Other Uses0.000.00-0.210.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.698.68-0.711.5219.0811.27
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.0016.546.000.000.12
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.0016.546.000.000.12
Proceedsfrom Stock Options0.000.00-5.955.950.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.130.000.000.000.000.00
Other Financing Activities Uses-0.130.000.000.000.000.00
Cash from Financing Activities-0.130.0016.546.000.000.12
Exchange Rate Effect-0.23-0.02-0.030.02-0.110.01
Net Change in Cash-13.30-5.304.29-4.499.581.07
Free Cash Flow-13.30-15.73-12.49-13.93-10.45-10.85

Revenue breakdown

Israel2024: 11.28M 2025: 13.02M
AI Solutions2024: 727.00K 2025: 958.00K
Nanox ARC2024: 281.00K 2025: 478.00K
Radiology Services2024: 10.28M 2025: 11.59M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.93%5.8M72.9M1.13M
2026-10-158.38%6.1M72.8M1.14M
2026-09-308.65%6.3M72.9M1.25M
2026-09-159.27%6.8M72.9M2.14M
2026-08-318.94%6.5M72.3M1.98M
2026-08-147.91%5.7M72.3M2.05M
2026-07-3110.44%6.7M64.0M2.05M
2026-07-1511.24%7.2M64.1M2.47M
2026-06-3010.34%7.2M69.3M2.36M
2026-06-1512.34%8.6M69.3M1.44M
2026-05-2914.61%10.1M69.3M1.39M
2026-05-1517.60%12.2M69.1M1.32M
2026-04-3019.13%13.2M69.0M1.35M
2026-04-1514.73%10.2M69.0M985.59K
2026-03-3115.99%10.1M63.5M972.24K
2026-03-1314.55%9.2M63.5M1.11M
2026-02-2715.07%9.6M63.5M1.22M
2026-02-1315.44%9.8M63.5M1.72M
2026-01-3013.78%8.7M63.5M1.66M
2026-01-1513.87%8.8M63.5M1.62M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.100.015.7713371400.559-0.0080.000
call1.000.000.050.056.3584160.000.318-0.0080.000
call1.500.000.050.017.7702510.000.295-0.0090.000
call2.000.000.050.058.59120.000.000.281-0.0090.000
call2.500.000.050.058.79551.000.000.273-0.0090.000
call5.000.000.050.0511.04399.000.000.258-0.0110.000
call7.500.000.050.0510.8241.000.000.214-0.0120.000
put0.500.000.200.144.94618.001.00-0.441-0.0080.000
put1.000.301.000.660.00032.000.00-0.679-0.0070.000
put1.500.751.451.1523.22029.000.00-0.705-0.0090.000
put2.001.251.951.8023.98320.000.00-0.719-0.0090.000
put2.501.752.452.3024.56890.000.00-0.727-0.0100.000
put5.004.205.204.800.00034.000.00-0.747-0.0110.000
put7.506.607.607.300.00014.000.00-0.755-0.0110.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-09SEC
2026-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-28SEC
2026-10-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-28SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-166-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-16SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-13SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-11SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-10SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-11SEC
2026-10-026-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-02SEC
2026-09-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-29SEC
2026-09-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-17SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-14SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-08-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-18SEC
2026-08-136-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-13SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-07SEC
2026-08-07424B5SEC
2026-08-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-06SEC
2026-08-04144Filing for proposed sale of securities under Rule 144.SEC
2026-08-033Initial statement of beneficial ownership of securities2026-08-01SEC
2026-07-29SCHEDULE 13G/ASEC
2026-07-294Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-294Statement of changes in beneficial ownership of securities2026-07-27SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1011.25K100
2026-0960.00K300
2026-089.73K100
2026-07109.68K300
2026-06001.12K1
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
ARK Investment Management LLC1.16%
MARSHALL WACE, LLP1.12%
MORGAN STANLEY0.94%
BlackRock, Inc.0.86%
AQR CAPITAL MANAGEMENT LLC0.81%
BANK OF AMERICA CORP /DE/0.66%
GOLDMAN SACHS GROUP INC0.50%
HRT FINANCIAL LP0.47%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.47%
Jain Global LLC0.44%

Funds

Fund% owned
State Street(R) SPDR(R) FTSE International Government Inflation-Protected Bond ETF11.49%
PIMCO Active Bond Exchange-Traded Fund3.59%
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND2.18%
VANGUARD DEVELOPED MARKETS INDEX FUND1.48%
Fidelity Low-Priced Stock Fund1.17%
ARK Israel Innovative Technology ETF1.16%
Fidelity Small Cap Index Fund0.99%
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND0.58%
VANGUARD RUSSELL 2000 INDEX FUND0.51%
iShares Micro-Cap ETF0.34%

OakChart. NNOX. Cached 15 minutes.